Specifically, the MIF-(CD47 + CXCR4) and MIF-(CD74 + CD44) interactions were found to be highly active in T cells, suggesting that MIF signaling may contribute to the regulation of T cell function within the NASH-HCC microenvironment. The gene discussed is CD44; the disease is hepatocellular carcinoma.